Addition of More Immunosuppressive Drugs As Graft-Versus-Host Disease (GVHD) Prophylaxis Does Not Improve Gvhd Outcomes in Reduced Intensity Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck‐Emmanuel Nicolini(Centre Léon Bérard), Nathalie Tedone(Hospices Civils de Lyon), Fiorenza Barraco(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Myriam Renault(Hospices Civils de Lyon), Mohamad Sobh(Ottawa Hospital), Caroline Lejeune(Hôpital Lyon Sud), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière(Hôpital Lyon Sud), Marie Balsat(Hôpital Claude Huriez)
Cited by 2
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547